An economic analysis of preimplantation genetic testing for aneuploidy (PGT-A) by polar body biopsy in advanced maternal age.
CONCLUSIONS: While avoiding unnecessary embryo transfers and miscarriages are important goals, patients and doctors need to be aware of the high cost implications of applying PGT-A using aCGH on polar bodies.
FUNDING: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The ESTEEM study was funded by the European Society for Human Reproduction and Embryology. Illumina provided microarrays and other consumables necessary for aCGH testing of polar bodies.
PMID: 31930663 [PubMed - as supplied by publisher]
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Neumann K, Sermon K, Bossuyt P, Goossens V, Geraedts J, Traeger-Synodinos J, Parriego M, Schmutzler A, van der Ven K, Rudolph-Rothfeld W, Vonthein R, Griesinger G Tags: BJOG Source Type: research
More News: Clinical Trials | Genetics | Grants | ICSI (Intracytoplasmic Sperm Injection) | Infertility | Miscarriage | OBGYN | Pregnancy | Reproduction Medicine | Study | Women